
---
title: '接种狂犬病疫苗后，抗体能维持多久_(3)'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=822587'
author: 科学网
comments: false
date: Thu, 16 Dec 2021 15:40:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=822587'
---

<div>   
<h1 style="margin-top:0;margin-right:0;margin-bottom:0;margin-left:0;text-indent:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: 'Microsoft YaHei';line-height: 200%;color: #2F496F;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Microsoft YaHei">接种狂犬病疫苗后，抗体能维持多久</span>?(</span></strong><strong><span style="font-family: 'Microsoft YaHei';line-height: 200%;color: #2F496F;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Microsoft YaHei">3</span></span></strong><strong><span style="font-family: 'Microsoft YaHei';line-height: 200%;color: #2F496F;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Microsoft YaHei">)</span></span></strong></h1><h1 style="margin-top:0;margin-right:0;margin-bottom:0;margin-left:0;text-indent:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: 'Microsoft YaHei';line-height: 200%;color: #2F496F;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Microsoft YaHei">（</span>WHO专题文献选译）</span></strong></h1><h1 style="margin-top:0;margin-right:0;margin-bottom:0;margin-left:0;text-indent:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%"><span style="color:#2f496f;font-family:Microsoft YaHei"><span style="font-size: 29px; background-color: #FFFFFF;">  </span></span><a style="text-indent: 51px; font-size: 16px;" name="OLE_LINK7" href="http://blog.sciencenet.cn/undefined"></a> <strong style="text-indent: 51px; font-size: 16px;"><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 24px;background: #FFFFFF">说明：</span></strong></h1><h1 style="margin-top:0;margin-right:0;margin-bottom:0;margin-left:0;text-indent:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%"><strong style="text-indent: 51px; font-size: 16px;"><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 24px;background: #FFFFFF">    2011年2月，WHO正式发布了《</span></strong><strong style="text-indent: 51px; font-size: 16px;"><span style="font-family: KaiTi;line-height: 200%;color: #C00000;letter-spacing: 0;font-size: 24px;background: #FFFFFF">疫苗接种的免疫学基础系列，第17分册：狂犬病(The Immunological Basis</span></strong><strong style="text-indent: 51px; font-size: 16px;"><span style="font-family: Tahoma;line-height: 200%;color: #C00000;letter-spacing: 0;font-size: 14px;background: #FFFFFF">　</span></strong><strong style="text-indent: 51px; font-size: 16px;"><span style="font-family: KaiTi;line-height: 200%;color: #C00000;letter-spacing: 0;font-size: 24px;background: #FFFFFF">for Immunization Series，Module 17: Rabies)</span></strong><strong style="text-indent: 51px; font-size: 16px;"><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 24px;background: #FFFFFF">》。此文献深入浅出地讲解了与狂犬病相关的免疫学基本知识，回答了人们普遍关心的许多理论问题和实践问题。本博客当年曾全文翻译了此文献。</span></strong></h1><h1 style="margin-top:0;margin-right:0;margin-bottom:0;margin-left:0;text-indent:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%"><strong style="text-indent: 51px; font-size: 16px;"><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 24px;background: #FFFFFF">    WHO于2017年对此文献进行了修订，更新了大量内容，可增进我们对狂犬病相关免疫学知识的系统认识和深入理解。本博客近期将陆续选择该</span></strong><strong style="text-indent: 51px; font-size: 16px;"><span style="text-decoration-line: underline;"><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 24px;background: #FFFFFF">更新版</span></span></strong><strong style="text-indent: 51px; font-size: 16px;"><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 24px;background: #FFFFFF">的较重要的内容进行介绍。</span></strong></h1><h1 style="margin-top:0;margin-right:0;margin-bottom:0;margin-left:0;text-indent:0;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%"><strong style="text-indent: 51px; font-size: 16px;"><span style="font-family: KaiTi;line-height: 200%;color: #0070C0;letter-spacing: 0;font-size: 24px;background: #FFFFFF">    本次介绍该文献的第3章：</span></strong></h1><p><strong><span style="font-family: 'Microsoft YaHei';color: #2F496F;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Microsoft YaHei">3. </span></span></strong><strong><span style="font-family: 'Microsoft YaHei';color: #2F496F;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Microsoft YaHei">接种狂犬病疫苗后，抗体能维持多久</span>?</span></strong><strong><span style="font-family: 'Microsoft YaHei';color: #2F496F;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Microsoft YaHei">（</span></span></strong><strong><span style="font-family: 'Microsoft YaHei';color: #2F496F;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:Microsoft YaHei">3）</span></span></strong></p><p style="margin-top:0;margin-right:0;margin-bottom:0;text-indent:24px;padding:0 0 0 0 "><strong><span style="font-family: StempelGaramond-Bold;font-size: 29px">3.3 </span></strong><strong><span style="font-family: SimSun;color: #2E3033;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:SimSun">记</span></span></strong><strong><span style="font-family: SimSun;color: #2E3033;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:SimSun">忆</span></span></strong><strong><span style="font-family: SimSun;color: #2E3033;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:SimSun">反</span></span></strong><strong><span style="font-family: SimSun;color: #2E3033;letter-spacing: 0;font-size: 29px;background: #FFFFFF"><span style="font-family:SimSun">应</span></span></strong><span style="font-family: SimSun;color: #2E3033;letter-spacing: 0;font-size: 21px;background: #FFFFFF"><span style="font-family:SimSun">（</span></span><span style="font-family: StempelGaramond-Bold;font-size: 21px">Anamnestic response</span><span style="font-family: StempelGaramond-Bold;font-size: 21px">）</span><strong><span style="font-family: StempelGaramond-Bold;font-size: 29px"> </span></strong></p><p><span style=";font-family:Calibri;font-size:14px"> </span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">赞成对有感染狂犬病风险的人进行预防</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">性</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">接种的两个</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">理由</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">是，如果先前接种过疫苗的人随后暴露于狂犬病</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">：</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family: StempelGaramond-Roman;font-size: 20px">1) </span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">更少针次的加</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">强</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">接种将引起快速的记忆反应，从而减少了一次完整的</span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">PEP</span></span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">（暴露后预防</span></span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">）</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">所需的疫苗剂量和访问次数</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family: StempelGaramond-Roman;font-size: 20px">2) </span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"> </span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">PEP</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">不</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">再</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">需要</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">昂贵的</span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">RIG</span></span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">（狂犬病免疫球蛋白</span></span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">）。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">一些已发表的临床试验提供了数据，证实以前接种过疫苗的人将对一</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">或多</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针的</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">狂犬疫苗加强</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针迅速</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">产生反应，即使最初的一系列</span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">PrEP</span></span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">（暴露前预防</span></span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">）</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">或</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">PEP</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">是在几年前</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">完成</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">的，无论最初的接种方案是</span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">IM</span></span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">（肌肉内</span></span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">）</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">还是</span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">ID</span></span><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">（皮内）</span></span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">，不管他们是通过</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">ID</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">还是</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">IM</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">途径进行</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">加</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">强，也不管之前接种疫苗的人</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">在接种加强针时</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">是否检测到</span><strong><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">VNA</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">（狂犬病毒中和抗体</span></span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">）。</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">长寿命的</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">能</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">分泌抗体的浆细胞</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">以及</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">记忆</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">性</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">B细胞和T细胞可能被独立</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">地</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">调控，因此在</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">免疫的</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">维持中发挥着</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">各自</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">不同的作用。这表明，</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">加强针可</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">激活记忆细胞，</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">同时</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">不影响长寿命抗体的</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">生产</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">，</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">从而能同时</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">确保短期和长期的免疫覆盖率。对</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">RVNA</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">水平高或低的人进行强化疫苗接种，</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">都</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">会导致循环</span>RVNA水平</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">增</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">高</span>;免疫系统被设计用来调节记忆细胞的激活，其机制依赖于针对靶抗原的特异性循环抗体水平</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"> <span style="font-family:StempelGaramond-Roman">一项为期三年的研究对</span>194名受试者进行了研究，这些受试者最初接受了1</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">、</span>2</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">或</span>3</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针</span><strong><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">HDCV</span></span></strong><strong><span style="text-decoration:underline;"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">（人二倍体细胞疫苗</span></span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">）</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">(通过ID或IM途径)，24个月后接受了1</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">HDCV(通过ID或IM途径)，</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">结果</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">接受初始</span>3</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">疫苗接种系列</span>(ID或IM)的受试者滴度最高</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">且</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">抗体持续时间最长。本研究中的所有受试者，无论他们是否接受了额外剂量的疫苗</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">，无论是经</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">ID</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">还是</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">IM</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">途径</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">，在</span>6个月、12个月或24个月后</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">打加强针都</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">有记忆反应。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">另一项研究报告称，</span>76名最初通过ID途径接种</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">HDCV</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">的人出现了记忆反应，然后在两年后通过</span>ID</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">接种一针</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">HDCV</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">加强针</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">。无论在</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">接种</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">前是否有可检测到抗体滴度，所有人都出现了记忆反应。在一项研究中报告了类似的结果，</span>29名旅行者最初</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">按</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">3</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">次</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">ID </span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">途径方案接种了</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">HDCV</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">，</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">2－</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">14个月后IM </span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">途径</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">接种</span>1</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">HDCV</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"> <span style="font-family:StempelGaramond-Roman">。在这项研究中，所有的人都产生了记忆反应，即使有些人在他们被</span></span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">加强接种</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">时没有检测到</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">抗体</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">滴度。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">还有</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">一项研究</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">评估了</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">57名</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"><span style="font-family:StempelGaramond-Roman">按</span>PEP方案</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">接种疫苗的患者的免疫应答，无论是</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">按</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">5</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">Essen方案还是</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">按</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">ID</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">途径</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px"> </span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">泰国红十字会</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">方案，在接受</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">加强针</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">疫苗</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">接种</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">后评估了随后的记忆反应。在</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">这项</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">研究中，患者在</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">5－</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">10年前接种</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">过</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">HDCV、PCECV、PVRV或PDEV，并在患者使用两</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">次</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">ID</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">途径接种</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">PDEV后进行</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">抗体</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">滴度评估。所有的患者在注射</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">加</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">强</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">针</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">后都出现了记忆</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">反应</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">，并且</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">5－</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">10年前接种</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">过</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">疫苗的患者和</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">超过</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">10年前接种</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">过</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">疫苗的患者的抗体水平</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">之间</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">没有显著差异。</span></p><p style="margin-left: 0;text-indent: 43px;line-height: 200%"><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">在另一项研究中，</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">对</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">118名</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">5－</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">21年前 </span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">按初次</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">PEP</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">或<strong>PrEP</strong></span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">方案</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">接</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">种过</span><strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">HDCV</span></strong><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">或<strong>PVRV</strong>的患者进行了免</span><span style="font-family: StempelGaramond-Roman;line-height: 200%;font-size: 20px">疫应答检查，使用两次ID途径接种<strong>PVRV</strong>作为加强针，以确定他们是否会引发记忆反应。在这项研究中，所有在长达21年前接种过疫苗的患者都出现了免疫应答，在原来按<strong>PrEP</strong>或<strong>PEP</strong>方案接种的患者的滴度水平之间没有显著差异，自首次接种以来的间隔时间的长度也对结果没有显著影响。</span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px">（</span></strong><strong><span style="font-family: SimSun;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px">未完待续</span></strong><strong><span style="font-family: SimSun;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px">）</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:46px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%;background:rgb(255,255,255)"><strong><span style="font-family: SimSun;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 21px">参考文献：</span></strong></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;margin-left:0;text-indent:43px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%;background:rgb(255,255,255)"><span style="font-family: Helvetica;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px">World Health Organization. (‎2017)‎. </span><strong><span style="font-family: Helvetica;line-height: 200%;color: #C00000;letter-spacing: 0;font-size: 20px">The immunological basis for immunization series: module 17: rabies</span></strong><strong><span style="font-family: Helvetica;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px">. </span></strong><em><span style="font-family: Helvetica;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px">World Health</span></em><em><span style="font-family: SimSun;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px"> </span></em><em><span style="font-family: Helvetica;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px">Organization</span></em><span style="font-family: Helvetica;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px">. </span></p><p style="margin-top:16px;margin-right:0;margin-bottom:16px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;line-height:200%;background:rgb(255,255,255)"><a href="https://apps.who.int/iris/handle/10665/259511" target="_blank"><span style="font-family: Helvetica;line-height: 200%;color: #6666CC;letter-spacing: 0;font-size: 20px">https://apps.who.int/iris/handle/10665/259511</span></a><span style="font-family: Helvetica;line-height: 200%;color: #333333;letter-spacing: 0;font-size: 20px">. License: CC BY-NC-SA 3.0 IGO</span></p><p style="margin-left:0;text-indent:46px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: SimSun;line-height: 200%;font-size: 21px">相关博文：</span></strong></p><p style="margin-left:0;text-indent:43px;text-autospace:ideograph-numeric;line-height:200%"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1316244" target="_blank"><img src="https://cors.zfour.workers.dev/?http://bbs.sciencenet.cn/home.php?mod=attachment&filename=image.png&id=822587" title alt="image.png" referrerpolicy="no-referrer"> <strong><span style="font-family: Tahoma;line-height: 200%;color: #6666CC;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:Tahoma">接种狂犬病疫苗后，抗体能维持多久</span>?(1) （WHO专题文献选译）</span></strong></a><span style="font-family: Tahoma;line-height: 200%;color: #666666;letter-spacing: 0;font-size: 20px;background: #FFFFFF"> 2021-12-12</span></p><p style="margin-left: 0px; text-indent: 43px; line-height: 200%;"><a href="https://blog.sciencenet.cn/home.php?mod=space&uid=347754&do=blog&id=1316511" target="_blank"><strong><span style="font-family: Tahoma;line-height: 200%;color: #6666CC;letter-spacing: 0;font-size: 20px;background: #FFFFFF"><span style="font-family:Tahoma">接种狂犬病疫苗后，抗体能维持多久</span>?(2)（WHO专题文献选译）</span></strong></a><span style="font-family: Tahoma;line-height: 200%;color: #666666;letter-spacing: 0;font-size: 20px;background: #FFFFFF"> 2021-12-14</span></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自严家新科学网博客。<br>链接地址：</label><a href="https://blog.sciencenet.cn/blog-347754-1316859.html" target="_blank" style="font-size:13px; color:#850f0f">https://blog.sciencenet.cn/blog-347754-1316859.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-347754-1316511.html" target="_black">接种狂犬病疫苗后，抗体能维持多久?(2)（WHO专题文献选译）</a><br>下一篇：<a href="http://blog.sciencenet.cn/blog-347754-1317055.html" target="_black">接种狂犬病疫苗后，抗体能维持多久?(4) （WHO专题文献选译）</a>                    <!--大赛结束-->
                                        
  
</div>
            